Arthur Tzianabos

Track

Insider profile

Currently holds positions in Akouos Inc, Stoke Therapeutics, Inc. and Q32 Bio Inc.

Positions

Position Company Period
Director Akouos Inc None -
Independent Director Stoke Therapeutics, Inc. Sept. 1, 2018 -
President, Chief Executive Officer, Director Q32 Bio Inc. Jan. 1, 2016 -
President, Chief Scientific Officer Tempest Therapeutics Inc Dec. 9, 2014 - March 31, 2016
President, Chief Executive Officer Q32 Bio Inc. None -
Chief Scientific Officer Tempest Therapeutics Inc July 30, 2013 - Dec. 9, 2014
Arthur Tzianabos's trades of Stoke Therapeutics, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Q32 Bio Inc. (QTTB)
Transaction date
Sale
Price
324.78
Quantity 2,864 +48.7%
Value US$1,952,934
US Q32 Bio Inc. (QTTB)
Transaction date
Planned sale
Price
0.57
Quantity 13,037 -9.2%
Value US$7,445
US Q32 Bio Inc. (QTTB)
Transaction date
Planned sale
Price
1.39
Quantity 10,616 -8.9%
Value US$14,762
US Q32 Bio Inc. (QTTB)
Transaction date
Planned sale
Price
3.78
Quantity 5,354 -5.9%
Value US$20,239
US Q32 Bio Inc. (QTTB)
Transaction date
Planned sale
Price
16.16
Quantity 12,500 -13.9%
Value US$202,021
US Q32 Bio Inc. (QTTB)
Transaction date
Planned sale
Price
20.50
Quantity 12,500 -12.2%
Value US$256,191
US Q32 Bio Inc. (QTTB)
Transaction date
Planned sale
Price
18.23
Quantity 100 -0.1%
Value US$1,823
US Q32 Bio Inc. (QTTB)
Transaction date
Planned sale
Price
17.39
Quantity 12,400 -8.9%
Value US$215,645
US Q32 Bio Inc. (QTTB)
Transaction date
Planned sale
Price
18.75
Quantity 12,500 -8.2%
Value US$234,320
US Q32 Bio Inc. (QTTB)
Transaction date
Planned sale
Price
18.98
Quantity 12,500 -7.0%
Value US$237,300
US Q32 Bio Inc. (QTTB)
Transaction date
Planned sale
Price
19.86
Quantity 12,500 -6.6%
Value US$248,262
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-12 2026-03-10
PlS Planned sale
90,530 -8.2%
209.17
US$3,221,512 		90,530 -8.2% 209.17 US$3,221,512
2026-03-10 2026-03-10
PrS Proposed sale
36,695
433.14
US$3,069,295 		36,695 433.14 US$3,069,295
2024-08-14 2024-03-25
US Q32 Bio Inc. (QTTB)
S Sale
2,864 +48.7%
324.78
US$1,952,934 		2,864 +48.7% 324.78 US$1,952,934
2024-02-15 2024-01-09
US Q32 Bio Inc. (QTTB)
PlS Planned sale
13,037 -9.2%
0.57
US$7,445 		13,037 -9.2% 0.57 US$7,445
2023-01-11 2023-01-09
US Q32 Bio Inc. (QTTB)
PlS Planned sale
10,616 -8.9%
1.39
US$14,762 		10,616 -8.9% 1.39 US$14,762
2022-01-12 2022-01-05
US Q32 Bio Inc. (QTTB)
PlS Planned sale
5,354 -5.9%
3.78
US$20,239 		5,354 -5.9% 3.78 US$20,239
2021-02-23 2021-02-19
PlS Planned sale
10,000 -100.0%
60.67
US$606,652 		10,000 -100.0% 60.67 US$606,652
2020-11-25 2020-11-23
PlS Planned sale
210 -100.0%
47.61
US$9,998 		210 -100.0% 47.61 US$9,998
2020-11-25 2020-11-23
PlS Planned sale
5,294 -96.2%
46.85
US$248,009 		5,294 -96.2% 46.85 US$248,009
2020-11-25 2020-11-23
PlS Planned sale
10,196 -64.9%
45.97
US$468,720 		10,196 -64.9% 45.97 US$468,720
2020-11-25 2020-11-23
PlS Planned sale
4,300 -21.5%
45.08
US$193,838 		4,300 -21.5% 45.08 US$193,838
2020-02-05 2020-02-03
US Q32 Bio Inc. (QTTB)
PlS Planned sale
12,500 -13.9%
16.16
US$202,021 		12,500 -13.9% 16.16 US$202,021
2020-01-03 2020-01-02
US Q32 Bio Inc. (QTTB)
PlS Planned sale
12,500 -12.2%
20.50
US$256,191 		12,500 -12.2% 20.50 US$256,191
2019-10-02 2019-10-01
US Q32 Bio Inc. (QTTB)
PlS Planned sale
100 -0.1%
18.23
US$1,823 		100 -0.1% 18.23 US$1,823
2019-10-02 2019-10-01
US Q32 Bio Inc. (QTTB)
PlS Planned sale
12,400 -8.9%
17.39
US$215,645 		12,400 -8.9% 17.39 US$215,645
2019-09-05 2019-09-03
US Q32 Bio Inc. (QTTB)
PlS Planned sale
12,500 -8.2%
18.75
US$234,320 		12,500 -8.2% 18.75 US$234,320
2019-07-03 2019-07-01
US Q32 Bio Inc. (QTTB)
PlS Planned sale
12,500 -7.0%
18.98
US$237,300 		12,500 -7.0% 18.98 US$237,300
2019-06-05 2019-06-03
US Q32 Bio Inc. (QTTB)
PlS Planned sale
12,500 -6.6%
19.86
US$248,262 		12,500 -6.6% 19.86 US$248,262